Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist used for type 2 diabetes management and weight loss
This is a normal effect of overall fat loss rather than a direct problem with the medication itself
CrossRef Development of a Lipidomics-Based Cell Screening Platform for Indirect Antioxidants Targeting Oxidized Lipid Droplet Formation and Mitochondrial Membrane Abnormality Yuzu Shibata, Toshihiro Sakurai, Akiko Sakurai, Misuzu Sato, Shu-Ping Hui Nutrients .2026
A 10-12 hour fast is still recommended for accurate fasting glucose, triglycerides, and certain other markers
The loophole is Section 503B of the Federal Food, Drug, and Cosmetic Act, which enables compounding facilities to produce knockoff versions of drugs that are in shortage